Júlio César Rocha

2.6k total citations
85 papers, 1.4k citations indexed

About

Júlio César Rocha is a scholar working on Clinical Biochemistry, Physiology and Molecular Biology. According to data from OpenAlex, Júlio César Rocha has authored 85 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Clinical Biochemistry, 62 papers in Physiology and 32 papers in Molecular Biology. Recurrent topics in Júlio César Rocha's work include Metabolism and Genetic Disorders (68 papers), Diet and metabolism studies (61 papers) and Mitochondrial Function and Pathology (20 papers). Júlio César Rocha is often cited by papers focused on Metabolism and Genetic Disorders (68 papers), Diet and metabolism studies (61 papers) and Mitochondrial Function and Pathology (20 papers). Júlio César Rocha collaborates with scholars based in Portugal, United Kingdom and Netherlands. Júlio César Rocha's co-authors include Anita MacDonald, François Feillet, Manuela Almeida, Kirsten Ahring, Francjan J. van Spronsen, Amaya Bélanger-Quintana, M. van Rijn, Alex Pinto, Nuno Borges and Anna Maria Lammardo and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Nutrients.

In The Last Decade

Júlio César Rocha

80 papers receiving 1.4k citations

Peers

Júlio César Rocha
Phyllis B. Acosta United States
Fran Rohr United States
Patricia M. Norton United States
Ellen Roitman United States
H. Ghadimi United States
Júlio César Rocha
Citations per year, relative to Júlio César Rocha Júlio César Rocha (= 1×) peers Kirsten Ahring

Countries citing papers authored by Júlio César Rocha

Since Specialization
Citations

This map shows the geographic impact of Júlio César Rocha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Júlio César Rocha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Júlio César Rocha more than expected).

Fields of papers citing papers by Júlio César Rocha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Júlio César Rocha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Júlio César Rocha. The network helps show where Júlio César Rocha may publish in the future.

Co-authorship network of co-authors of Júlio César Rocha

This figure shows the co-authorship network connecting the top 25 collaborators of Júlio César Rocha. A scholar is included among the top collaborators of Júlio César Rocha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Júlio César Rocha. Júlio César Rocha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rocha, Júlio César, Á. Hermida Ameijeiras, Sarah Rose, et al.. (2024). Meta-analysis of bone mineral density in adults with phenylketonuria. Orphanet Journal of Rare Diseases. 19(1). 338–338. 1 indexed citations
2.
Rocha, Júlio César, Kirsten Ahring, Deborah A. Bilder, et al.. (2023). Expert Consensus on the Long-Term Effectiveness of Medical Nutrition Therapy and Its Impact on the Outcomes of Adults with Phenylketonuria. Nutrients. 15(18). 3940–3940. 3 indexed citations
3.
Pérez, Luis Miguel Luengo, Luís Pereira‐da‐Silva, André Moreira-Rosário, et al.. (2023). Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with Phenylketonuria. Nutrients. 15(24). 5133–5133. 3 indexed citations
4.
Almeida, Manuela, et al.. (2023). Total Protein Intake in Patients with PKU: Adequacy Evaluation According to the European PKU Guidelines from 2017. Nutrients. 15(23). 4883–4883. 1 indexed citations
5.
Daly, Anne, Catherine Ashmore, Sharon Evans, et al.. (2023). Impact on Diet Quality and Burden of Care in Sapropterin Dihydrochloride Use in Children with Phenylketonuria: A 6 Month Follow-Up Report. Nutrients. 15(16). 3603–3603. 2 indexed citations
6.
Pinto, Alex, Ana Faria, Diana Teixeira, et al.. (2021). Is the Phenylalanine-Restricted Diet a Risk Factor for Overweight or Obesity in Patients with Phenylketonuria (PKU)? A Systematic Review and Meta-Analysis. Nutrients. 13(10). 3443–3443. 34 indexed citations
7.
Costa, Raquel, Ilda Rodrigues, Sandra Martins, et al.. (2021). Unveiling the Metabolic Effects of Glycomacropeptide. International Journal of Molecular Sciences. 22(18). 9731–9731. 3 indexed citations
8.
Bandeira, Anabela, et al.. (2020). TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW. Revista Paulista de Pediatria. 38. e2018158–e2018158. 7 indexed citations
9.
Cannet, Claire, Andrea Pilotto, Júlio César Rocha, et al.. (2020). Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation. Orphanet Journal of Rare Diseases. 15(1). 61–61. 17 indexed citations
10.
MacDonald, Anita, Annemiek M. J. van Wegberg, Kirsten Ahring, et al.. (2020). PKU dietary handbook to accompany PKU guidelines. Orphanet Journal of Rare Diseases. 15(1). 171–171. 126 indexed citations
11.
Daly, Anne, Sharon Evans, Saikat Santra, et al.. (2019). Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU. Orphanet Journal of Rare Diseases. 14(1). 44–44. 22 indexed citations
12.
Pinto, Alex, Manuela Almeida, Esmeralda Martins, et al.. (2017). Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source. European Journal of Clinical Nutrition. 71(10). 1230–1234. 29 indexed citations
13.
Rocha, Júlio César, Manuela Almeida, Esmeralda Martins, et al.. (2015). Infantile Refsum Disease: Influence of Dietary Treatment on Plasma Phytanic Acid Levels. JIMD Reports. 26. 53–60. 6 indexed citations
14.
Dokoupil, Katharina, Hülya Gökmen-Özel, Anna Maria Lammardo, et al.. (2011). Optimising growth in phenylketonuria: Current state of the clinical evidence base. Clinical Nutrition. 31(1). 16–21. 27 indexed citations
15.
MacDonald, Anita, Kirsten Ahring, Katharina Dokoupil, et al.. (2011). Adjusting diet with sapropterin in phenylketonuria: what factors should be considered?. British Journal Of Nutrition. 106(2). 175–182. 22 indexed citations
16.
Rocha, Júlio César, et al.. (2010). BODY COMPOSITION AND MARKERS OF METABOLIC SYNDROME IN ADULTS WITH PKU. Journal of Inherited Metabolic Disease. 33. 3 indexed citations
17.
Rocha, Júlio César, Manuela Almeida, Maria Luı́s Cardoso, et al.. (2010). The Use of Prealbumin Concentration as a Biomarker of Nutritional Status in Treated Phenylketonuric Patients. Annals of Nutrition and Metabolism. 56(3). 207–211. 23 indexed citations
18.
Rocha, Júlio César, et al.. (2009). PROTEIN INSUFFICIENCY AND LOW HEMOGLOBIN IN PHENYLKETONURIC PATIENTS. Open Repository of the University of Porto (University of Porto). 1 indexed citations
19.
Rocha, Júlio César, et al.. (2008). The importance of prealbumin concentration in phenylketonuric patients. Journal of Inherited Metabolic Disease. 31. 145–145. 2 indexed citations
20.
Rocha, Júlio César, et al.. (1989). Determinação Espectrofotométrica de Amônio em Extratos de Carne, com Salicilato e Hipoclorito, sem Prévia Neutralização dos Digeridos Sulfúricos. Química Nova. 12(4). 309–312. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026